1 Ambroggi et al. World Journal of Surgical Oncology 2014, 12:129 WORLD JOURNAL OF SURGICAL ONCOLOGY CASE REPORT Open Access Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review Massimo Ambroggi 1, Elena Orlandi 1, Raoul P Foroni 2 and Luigi Cavanna 1* Abstract Background: Malignant mesothelioma is a rare neoplasm that generally develops in the pleural or peritoneal cavity. Distant metastases are common; it rarely metastatizes to the head and neck region. Case presentation: A 54-year-old white man, a non-smoker, was treated with chemotherapy, surgery and radiation for a malignant pleural mesothelioma. Seven months after the last treatment, he developed a right submandibular enlargement: clinical examination, ultrasound and computerized tomography scans revealed a salivary gland hypertrophy. Anti-inflammatory and antibiotic treatment was then started, without improvement. An ultrasound (US)-guided fine-needle aspiration biopsy (FNAB) showed atypical mesothelial cells with nuclear enlargement and increased chromatin representation. Immunocytochemistry showed positivity for calretinin and WT-1. A diagnosis of right submandibular salivary gland involvement from mesothelioma was established, allowing an adequate treatment. Conclusion: We report a very rare site of metastasis from malignant pleural mesothelioma. We suggest that US-guided FNAB is a useful, quick, and cheap procedure for a definite diagnosis. Keywords: Mesothelioma, Salivary gland metastasis, Fine needle aspiration Background Malignant mesothelioma is a rare neoplasm with an incidence rate of 1 per 100,000 (both sexes, United States) . Approximately 80% of cases of mesothelioma develop in the pleural cavity, whereas the other 20% arise in the peritoneum; the pericardium is affected very rarely . Metastases from malignant mesothelioma are common, usually to the local lymph nodes, pleurae of the contralateral lung, bone, liver and brain . However, metastases to the head and neck region are uncommon but the jaw bones, particularly the mandibular molar * Correspondence: 1 Department of Oncology and Hematology, Oncology Unit, Azienda Ospedaliera Guglielmo da Saliceto, Via Taverna 49, Piacenza, Italy Full list of author information is available at the end of the article area, are more likely to be the site of metastases than the perioral region [4-19]. We present a 54-year-old man, a non-smoker, with no occupational exposure to asbestos with malignant pleural mesothelioma, previously treated with surgery, radiotherapy and chemotherapy. He presented with right submandibular salivary gland enlargement, diagnosed using US and computerized tomography (CT) scan imaging techniques, as salivary gland hypertrophy, while a fine-needle aspiration biopsy (FNAB) showed metastasis from malignant mesothelioma. Case presentation A 54-year-old Caucasian man underwent right pleural biopsy in December 2005 for recurrent pleural effusion and locally advanced malignant mesothelioma was 2014 Ambroggi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
2 Ambroggi et al. World Journal of Surgical Oncology 2014, 12:129 Page 2 of 5 diagnosed. Subsequently, he was treated with chemotherapy containing cisplatin and pemetrexed for seven cycles; CT scan showed a partial response. In December 2006, he underwent surgery involving total right pleuropneumonectomy plus partial resection of the pericardium and diaphragm. The histological features showed epithelioid malignant mesothelioma involving the parietal and the visceral pleurae, the lung, the pericardium and the diaphragm. Subsequent radiotherapy to the right chest was administered using 50.4 Gy, 28 fractions. The patient remained disease-free until June 2009 when an isoechogenic and hypodense nodule of mm was discovered on US and CT scan in the right side of the anterior abdominal wall. An ultrasoundguided biopsy showed metastasis of mesothelioma. In August 2009, the nodule was surgically removed, and radiotherapy was then administered to this site using 45 Gy, 15 fractions. In September 2011, a relapse in the mediastinum (lymph nodes) was found by CT scan and Positron Emission Tomography (PET), so six cycles of chemotherapy with cisplatin and pemetrexed were started which lasted until January Complete response at PET examination in February 2012 was demonstrated. In November 2012, a right submandibular salivary gland tumefaction was recorded. US examination showed right submandibular gland hypertrophy (Figure 1), confirmed on CT scan and with neither US nor CT signs of metastasis; a diagnosis of inflammation of the gland was made. Anti-inflammatory therapy was administered; the patient also received antibiotic therapy but without improvement. An US-guided FNAB of the right submandibular salivary gland was then performed using a 22-gauge needle and showed atypical mesothelial cells, with nuclear enlargement and increased chromatin representation (Figure 2). Immunocytochemistry showed positivity for calretinin (Figure 3) and nuclear, weak and focal positivity for WT-1 (Figure 4). Based on the previous history of malignant mesothelioma and the morphologic features of the cells, immunocytochemistry allowed confirmation of the diagnosis of right submandibular involvement from epithelioid mesothelioma. The subsequent PET scan was positive for the right submandibular salivary gland. The patient was treated with radiotherapy to this site. Literature review A computerized literature search through MEDLINE, Cancerlit and Embase was performed, in order to make a comparison with our case, applying the words: mesothelioma', metastasis', oral cavity', mouth', buccal', tongue', head and neck area. Articles and abstracts were also identified by back-referencing from original and relevant papers. Selected for the present review were papers published in English before April Conclusion With this case report, we would like to focus on two aspects: 1) metastases from mesothelioma to the head and neck area (except for lymph nodes), in particular to the salivary glands, are very rare; 2) diagnosis of metastasis from mesothelioma is made usually by biopsy, and not by FNAB as in our case (Table 1). Figure 1 Ultrasound image showing a right submandibular salivary gland enlargement with a low-echogenic pattern.
3 Ambroggi et al. World Journal of Surgical Oncology 2014, 12:129 Page 3 of 5 Figure 2 Fine-needle aspiration biopsy (FNAB) of right submandibular salivary gland shows atypical mesothelial cells with nuclear enlargement and increased chromatin representation (A) and normal salivary gland cells ((B) acinar cells; (C) ductal cells). May-Grünwald- Giemsa (MGG) x40. Reviewing the literature, we found 17 other cases of metastases to the head and neck area (except for lymph nodes) from mesothelioma, but none to the salivary glands. The most involved site was the tongue, with different clinical presentations, followed by the mandible and in particular the mandibular alveolus, and then the oral mucosa. The clinical presentation can be of a benign polypoid-like lesion of the tongue or a radicular cyst in the mandibular alveolus, with only cyto-histological examination allowing a definite diagnosis. The diagnosis of primary malignant mesothelioma is established by a combination of clinical, imaging, histopathological and immunohistochemical features. The diagnosis of a secondary mesothelioma is easier and can be made more rapidly since there is a previous diagnosis of the primary lesion . However, even with the Figure 3 Fine-needle aspiration biopsy (FNAB) of right submandibular salivary gland shows neoplastic mesothelial cells positive for calretinin (A) and normal acinar glandular cells (B). Immunocytochemistry, Fast red N.4.
4 Ambroggi et al. World Journal of Surgical Oncology 2014, 12:129 Page 4 of 5 Figure 4 Fine-needle aspiration biopsy (FNAB) of right submandibular salivary gland, showing nuclear, weak and focal, immunocytochemically WT-1 positive mesothelioma cells (A) and normal acinar salivary gland cells (B). Immunocytochemistry, DAB. knowledge of a primary mesothelioma it is necessary to perform a definite diagnosis of a putative lesion to allow appropriate management of the patient. Reviewing the literature, in almost all cases of head and neck metastases from mesothelioma, incisional or excisional biopsy was performed to obtain the diagnosis; in some cases surgical excision was needed. We found no cases diagnosed by FNAB. Fine-needle aspiration biopsy (FNAB) is a clinically accepted, minimally invasive technique that allows sampling of tumor for diagnosis by percutaneously directing a needle into the target lesion guided either by direct palpation or under image guidance . In general, the accuracy, specificity and sensitivity of FNAB results depend on the size of the lesion, the method of biopsy, and the histology of the tumor . When FNAB is applied as a diagnostic technique in patients with suspected malignant mesothelioma, the accuracy of diagnosis may be low. Though the cytologic diagnostic features of malignant mesothelioma were described more than 50 years ago, there is still doubt as to the ability of the cytopathologic modality to obtain a definitive diagnosis of malignant mesothelioma [22-24]. The published sensitivity of cytologic diagnosis of mesothelioma ranges between 32% and 76%, and this wide range of sensitivity is probably related to the sampling technique rather than the interpretation . It must be emphasized that application of immunocytochemical and molecular techniques greatly enhance Table 1 Review of head and neck (except for lymph node) metastases from mesothelioma published in the literature Site of metastasis Number of patients Clinical presentation Diagnostic modality References Tongue 7 Tongue lesion, nodular consolidation of the tongue with chronic bleeding, submucosal mass, horizontal fissure, swelling of the dorsal surface of the tongue, polypoid lesion Mandible 4 Radicular cyst, mandibular gingival mass, periapical radiolucency Surgery, lingual incisional and excisional biopsy Excision of the tooth, biopsy, incisional biopsy, excision of the mass [5,7,10,14-16,18] [5,6,8,12] Oral mucosa 3 Submucosal mass Biopsy [11,17,19] Lips 1 Lip lesion Lip biopsy  Conjunctiva 1 n/a n/a  Thyroid 1 n/a n/a  Total 17 We collected the previously published cases of metastases from mesothelioma to the head and neck area, except for lymph node metastases. Tongue was the most frequent site of metastases, with different clinical presentations; no metastases to the salivary glands had previously been found, and no diagnoses of metastases with FNAB had been made.
5 Ambroggi et al. World Journal of Surgical Oncology 2014, 12:129 Page 5 of 5 the diagnostic accuracy of cytologic diagnosis of malignant mesothelioma [25-27]. FNAB biopsies are an ideal method for detecting tumor relapse during the life cycle of the cancer , as demonstrated in our case where the imaging techniques of US and CT scans suggested only salivary gland hypertrophy, while FNAB confirmed mesothelioma relapse. This case is interesting in that it demonstrates a rare site of metastasis from malignant mesothelioma, and shows the efficacy of FNAB for a definite cytologic diagnosis, thus allowing optimum treatment. Consent Written informed consent was obtained from the patient for the publication of this report and any accompanying images. Abbreviations FNAB: fine needle aspiration biopsy; US: ultrasound; CT: computerized tomography; PET: Positron Emission Tomography. Competing interests The authors declare that they have no competing interests. Authors contributions MA and EO took care of the clinical case presentation and revised the literature. LC revised the literature and FNAB use, and wrote discussion and conclusion. RPF took care of the pathological aspects and provided cytological figures. All authors read and approved the final manuscript. Author details 1 Department of Oncology and Hematology, Oncology Unit, Azienda Ospedaliera Guglielmo da Saliceto, Via Taverna 49, Piacenza, Italy. 2 Department of Pathology, Azienda Ospedaliera Guglielmo da Saliceto, Via Taverna 49, Piacenza, Italy. Received: 16 August 2013 Accepted: 7 April 2014 Published: 28 April 2014 References 1. SEER Cancer Statistics Review (CSR) Brenner J, Sordillo PP, Magrill GB, Golbey RB: Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982, 49: King JA, Tucker JA, Wong SW: Mesothelioma: a study of 22 cases. South Med J 1997, 90: Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R: Metastatic tumours to the oral cavity: pathogenesis and analysis of 673 cases. Oral Oncol 2008, 44: Kerpel SM, Freedman PD: Metastatic mesothelioma of the oral cavity. Oral Surg Oral Med Oral Pathol 1993, 76: Sproat CP, Brown AE, Lindley RP: Oral metastasis in malignant pleural mesothelioma. Br J Oral Maxillofac Surg 1993, 31: Piattelli A, Fioroni M, Rubini C: Tongue metastasis from a malignant diffuse mesothelioma of the pleura: report of a case. J Oral Maxillofac Surg 1999, 57: Garcia-Reija MF, Matilla JM, De Paz A, Sanchez-Cuellar A, Verrier A: Unusual metastasis to the mandibular alveolus of malignant pleural mesothelioma. Otolaryngol Head Neck Surg 2002, 126: Cassarino DS, Xue W, Shannon KJ: Widespread cutaneous and perioral metastases of mesothelioma. J Cutan Pathol 2003, 30: Zanconati F, Delconte A, Bonifacio-Gori D, Falconieri G: Metastatic pleural mesothelioma presenting with solitary involvement of the tongue: report of a new case and review of the literature. Int J Surg Pathol 2003, 11: Soyuer I, Soyuer S, Canöz Ö, Coşkun S, Balkanli S: Three patients with unusual metastases. Cytopathology 2004, 15: Terakado N, Shintani S, Nakashiro K, Hamakawa H: Malignant pleural mesothelioma metastasis to the mandible. Int J Oral Maxillofac Surg 2004, 33: Tho LM, O Rouke NP: Unusual metastases from malignant pleural mesothelioma. Clin Oncol (R Coll Radiol) 2005, 17:293. abstract. 14. Glazer CA, Waldman EH, Ansari-Lari AM, Broussard JN, Brahmer J, Tufano RP: Pathology quiz. Arch Otolaryngol Head Neck Surg 2006, 132(1012): Higginson DS, Brahmer J, Tufano RP, Bajaj GK: Pleural mesothelioma metastatic to the tongue. J Clin Oncol 2007, 25: Hashitani S, Sakurai K, Takaoka K, Urade M: Metastatic malignant pleural mesothelioma of the tongue: report of a case. Brit J Oral Maxillofac Surg 2009, 47: Kirke D, Horwood K, Wallwork B: Floor of mouth and tongue metastasis from malignant pleural mesothelioma. ANZ J Surg 2010, 80: Murray LJ, Higham J, Suvarna SK, Craig GT, Bridgewater CH, Fisher PM, Thornhill MH: Oral presentation of malignant mesothelioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111:e21 e Sinon SH, Rich AM, Hussaini HM, Yoon HS, Firth NA, Seymour GJ: Metastases to the oral region from pleural mesothelioma: clinicopathologic review. Head Neck 2013, 35(4): Cavanna L, Lazzaro A, Vallisa D, Civardi G, Artioli F: Role of image-guided fine-needle aspiration biopsy in the management of patients with splenic metastasis. World J Surg Oncol 2007, 5: Vilmann P, Saftoiu A: Endoscopic ultrasound-guided fine needle aspiration biopsy: equipment and technique. J Gastroenterol Hepatol 2006, 21: Whitaker D: The cytology of malignant mesothelioma. Cytopathology 2000, 11(3): Sheaff M: Should cytology be an acceptable means of diagnosing malignant mesothelioma? Cytopathology 2011, 22(1): Husain AN, Colby T, Ordomnez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M, International Mesothelioma Interest Group: Guidelines for pathologic diagnosis of malignant mesothelioma update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2013, 137(5): Au AY, Hackl T, Yeager TR, Cohen SB, Pass HI, Harris CC, Reddel RR: Telomerase activity in pleural malignant mesotheliomas. Lung Cancer 2011, 73(3): Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T: Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations. Diagn Cytopathol 2011, 39(6): Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T: IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology. Hum Pathol 2010, 41(5): De Rienzo A, Dong L, Yeap BY, Jensen RV, Richards WG, Gordon GJ, Sugarbaker DJ, Bueno R: Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 2011, 17: doi: / Cite this article as: Ambroggi et al.: Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review. World Journal of Surgical Oncology :129.
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 email@example.com
Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis . Most are
Staging of Lung Carcinoma: Explaining the AJCC 7 th edition Kirk D. Jones, MD UC San Francisco Department of Pathology Introduction Historical aspects Changes to the T component Tumor size and measurement
For media outside the US, UK and Canada only P L E U R A L M E S O T H E L I O M A 1. Overview 2. What is pleural mesothelioma? 3. How common is pleural mesothelioma? 4. What are the risk factors for pleural
PET-CT in Lung Cancer: Merging Anatomic and Metabolic Diagnosis Paul Shreve, M.D. Advanced Radiology Services, P.C. Society of Nuclear Medicine Annual Meeting 2004 Philadelphia PET-CT Scanners Why PET-CT?
ONCOLOGY LETTERS 8: 2125-2129, 2014 Primary neuroendocrine tumors of the thymus: Clinical review of 22 cases ZHENGBO SONG 1,2 and YIPING ZHANG 1,2 1 Department of Chemotherapy, Zhejiang Cancer Hospital;
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
Volume 2013, Article ID 198729, 4 pages http://dx.doi.org/10.1155/2013/198729 Case Report Pleural Mesothelioma Presenting as Periumbilical Metastasis: The First Clinical Documentation R. F. Falkenstern-Ge,
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
Thoracic Surgery Case Studies How would you manage (investigate and treat) the following patients? 65-year-old female ex-smoker was found to have a 2cm mass in the right upper zone of the lung on a screening
OROPHARYNGEAL NEOPLASIA IN THE DOG AND CAT Richard Walshaw, BVMS, Diplomate ACVS Member VSSO Animal Cancer & Imaging Center, Canton, Michigan Incidence: Oropharyngeal neoplasia accounts for approximately
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); firstname.lastname@example.org Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Kobe J. Med. Sci., Vol. 55, No. 3, pp. E67-E72, 2009 Metastasis to the Lingual Lymph Node in Patients with Squamous Cell Carcinoma of the Floor of the Mouth: A Report of Two Cases MASAHIRO UMEDA*, TSUTOMU
Buccal Space Masses David W. Eisele, M.D., F.A.C.S. Head and Neck Surgery and Oncology U.C.S.F. Helen Diller Family Comprehensive Cancer Center University of California, San Francisco Buccal Space Mass
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
Malignant Adenomyoepithelioma of the Breast with Lymph Node Metastasis Ahlam A. Awamleh * Mihir Gudi, Sami Shousha ^ * King Hussein Medical Center, Amman Jordan ^ Charing Cross Hospital, London, UK Introduction
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
PET/CT Imaging in Lung Cancer Mylene T. Truong, MD Mylene T. Truong M.D. Objectives To discuss the role of PET/CT in the staging of lung cancer To review the recommendations from American Society of Clinical
Sasan Dabiri, M.D. - Assistant Professor Department of Otorhinolaryngology Head & Neck surgery Amir A lam hospital Tehran University of Medical Sciences Overall prevalence: Epidemiology 3% of Head & Neck
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco Palpable Breast masses Fine needle aspiration biopsy
Established set of general parameters General parameters for lung cancer detection it is characteristics of patient and the diagnosis methods with results. Patient Characteristics Initial patient characteristic,
Head & Neck Lumps & Bumps R S Allison Department of Otolaryngology, Head & Neck Surgery Christchurch Hospital August 2010 OVERVIEW Neck Lumps: Children Head & Neck Tumours Neck Lumps: Adults Salivary Glands
STAGING OF NON SMALL CELL LUNG CANCER Characteristics of a Clinically Useful Test Acceptable error rate - Sensitivity, specificity, accuracy Unique information - Patho-physiologic information different
TITLE: Malignancies of the Major Salivary Glands SOURCE: Grand Rounds Presentation, UTMB, Dept. of Otolaryngology DATE: May 23, 2007 RESIDENT PHYSICIAN: Chad Simon, MD FACULTY ADVISOR: Susan D. McCammon,
Introduction to Small Cell Lung Cancer: Prevalence, Initial Symptoms, Work-Up, and Staging General Introduction to Small Cell Lung Cancer Lung cancer consists of two major types: small cell lung cancer
PET/CT Imaging in the Head and Neck Cancer Patient Patrick K. Ha, MD Johns Hopkins Department of Otolaryngology Johns Hopkins Head and Neck Surgery at GBMC Milton J Dance Jr. Head and Neck Center 11 th
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
Bahrain Medical Bulletin, Vol. 30, No. 2, June 2008 Fat Necrosis Following Breast Cancer Surgery and Radiotherapy Suhair Al-Saad, MBChB, FRCS I, CABS* Background: Local recurrence is the most devastating
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
Pre-PET Form Comment to Clinician: You have requested an F-18 Fluoride PET scan, a test for which the Centers for Medicare and Medicaid Services (CMS) requires pre- and post-pet information from the referring
Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
WHAT S NEW IN BREAST IMAGING Patricia Hassell BCCA Magnetic Resonance Imaging Positron Emission Tomography/PET Ultrasound Digital Mammography 1 BREAST MRI Improved spatial resolution of surface coils Use
A succesfull case of HIPEC in a peritoneal mesothelioma patient Firmino, NLJ¹²; Miranda, E¹³; Oliveira, DA ²; Lima, MBA ¹²; Diniz, AF ¹²; Gomes, GES ¹²; Azevedo, LW ¹²; Soares,MC¹²; Gomes, ASA³. ¹Pernambuco
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
17 Lung Tumors Hossein Jadvar and Sherief Gamie Case 17.1 History 57-year-old male with known right-sided malignant mesothelioma. The current study is being done to evaluate extent of disease. Findings
Salivary Gland Neoplasms Wayne J. Harsha, MD MAJ, MC, USA Madigan Army Medical Center Tacoma, WA I have no conflict of interest to declare in regards to the contents of this lecture material. The views
NECK MASSES DR THOMAS LOH, MBBS, FRCS Head & Neck Surgeon Head & Neck Surgical Oncology Department Of Otolaryngology Head & Neck Surgery, National University Hospital Department Of Otolaryngology, National
401 Fig. 2. A 38-year-old man with papillary carcinoma. Longitudinal sonogram of right thyroid lobe shows a solid mass with Type 1 peripheral nodular calcification. The histopathologic results of preoperative
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Medications Lifestyle Changes Living With Thyroid Cancer Talking
CYTOLOGICAL DIAGNOSIS OF A RARE CASE OF ANAPLASTIC CARCINOMA OF THYROID IN A YOUNG WOMAN Neha Dandona 1, Deepa Hatwal 2, Sanjul Dandona 3, Sheela Chowdhary 4, Pawan Bhatt 5 HOW TO CITE THIS ARTICLE: Neha
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Metastatic Cancer: Questions
Case Reports in Pulmonology Volume 2015, Article ID 962504, 4 pages http://dx.doi.org/10.1155/2015/962504 Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement
METABOLIC PET IMAGING FOR A NEW RADIOTHERAPY METASTASES: TECNOLOGICAL INNOVATION AND RESOURCES RATIONALIZATION CORRADO BONI Reggio Emilia, 4-5 October 2005 Oncologic indications for FDG-PET approved by
False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
Iranian Journal of Otorhinolaryngology Vol. 22, No.61, Autumn-2010, Original Article Diagnostic Efficacy of Fine Needle Aspiration in Parotid Mass Ebrahim Razmpa 1,*Babak Saedi 2, Majid Partomanesh 3 Abstract
Malignancies of the Major Salivary Glands Chad Simon, MD Faculty Advisor: Susan D. McCammon, MD Grand Rounds Presentation Department of Otolaryngology The University of Texas Medical Branch at Galveston
RESPONSE ASSESSMENT Response to therapy is the primary endpoint of most Phase II studies and a secondary endpoint of some Phase III studies. To assess a patient's response to therapy correctly, the study
O COLON MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff
Int J Clin Exp Pathol 2014;7(5):2636-2640 www.ijcep.com /ISSN:1936-2625/IJCEP0000187 Case Report Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child Qihan You 1, Jing
Cancer of the Mouth Explained Patient Information Introduction This leaflet tells you about the condition known as cancer of the mouth, or oral cancer. We hope it will answer some of the questions that
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
October-November, 2002 PET Scanning for Malignant Melanoma: An Evidence Based Approach Adam L. Cohen, Harvard Medical School Year III Patient SW 40 yo woman s/p melanoma resection on right arm, who presented
International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
HPV-Related Head and Neck Cancer James V. Zirul, D.O. Combined ACP and AKOMA Conference 09.Apr.2015 ANATOMY ORAL CAVITY Anterior 2/3 tongue, retromolar trigone area (posterior to the molars) and hard palate
Liver Imaging Patricia Lipford Abbitt,, MD Professor and Chief - Body Imaging Section Department of Radiology College of Medicine University of Florida Liver Imaging/Cirrhosis Number of patients with hepatitis
1 Principles of Cancer Therapy Professor Mark McKeage Dept of Pharmacology & Clinical Pharmacology The University of Auckland 2 Cancer in New Zealand Cancer is a common clinical problem in NZ 21,050 new
Beth Israel Deaconess Medical Center Harvard Medical School Bronchioloalveolar carcinoma: imaging findings and follow-up Sona Chikarmane Advanced Radiology Clerkship, BIDMC May 19, 2008 Agenda: Patient